Cadrock Secures US$5m for Therapy Targeting $35 billion Heart Disease Market
Sep 04, 2018 09:00 HKT |  |
|
Genexi Biotech Accelerator. The Platform MVP Release
Aug 20, 2018 17:00 HKT |  |
|
Ascletis Successfully Listed on the Main Board of HKEX
Aug 01, 2018 21:02 HKT | |
|
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA
Aug 01, 2018 18:35 HKT | |
|
Ascletis-developed Ganovo Acquired Extraordinary Achievement
Jul 31, 2018 20:30 HKT | |
|
NANOBIOTIX signs a 40M EUR non-dilutive financing agreement with the European Investment Bank
Jul 27, 2018 07:00 HKT |  |
|
Scientists Discover the Tuberal Nucleus' Role in Controlling Appetite and Body Weight
Jul 13, 2018 10:00 HKT |  |
|
Autolus Announces Pricing of Initial Public Offering
Jun 22, 2018 10:00 HKT |  |
|
NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3
Jun 22, 2018 09:00 HKT | |
|
HKBU scholars invent award-winning medical device for safe growth of neural stem cells using nanotechnology
Jun 21, 2018 11:00 HKT |  |
|
Blood vessel-forming cells involved in aggressive brain tumour
Jun 20, 2018 10:00 HKT |  |
|
Singapore eDevelopment Limited Announces Corporate and Business Update
Jun 18, 2018 19:00 HKT |  |
|
NANOBIOTIX' Management Statement on Recent Share Price Variation
Jun 06, 2018 22:00 HKT | |
|
Proteomics International signs with PrismHealthDx for US launch of PromarkerD predictive test for diabetic kidney disease
Jun 04, 2018 11:00 HKT |  |
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar
May 31, 2018 18:00 HKT | |
|
HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker
May 16, 2018 10:00 HKT | |
|
Helsinn Group announces the launch of the IV formulation of AKYNZEO(R) (fosnetupitant/palonosetron) in the United States
May 09, 2018 09:00 HKT |  |
|
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers
May 04, 2018 09:00 HKT | |
|
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Apr 20, 2018 22:10 HKT | |
|
LEH PHARMA LTD.: Company Update
Apr 18, 2018 20:30 HKT |  |
|